Credit Suisse Upgrades Roche (RHHBY) to Outperform; Defensive Outlook Should Underpin Dividends
Tweet
Share
E-mailGet Alerts RHHBY Hot Sheet
Price: $54.52 -1.75%
Rating Summary:
5 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Credit Suisse upgraded Roche (OTC: RHHBY) from Neutral to Outperform.
For an analyst ratings summary and ratings history on Roche click here. For more ratings news on Roche click here.
Shares of Roche closed at $41.80 yesterday.
For an analyst ratings summary and ratings history on Roche click here. For more ratings news on Roche click here.
Shares of Roche closed at $41.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- JPMorgan Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Kepler Cheuvreux Upgrades Swissquote Group Holding SA (SQN:SW) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit Suisse, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
